Powderject Pharma
Article Abstract:
Powderject Pharmaceuticals has secured a British government contract, though there is some concern about drugs departing from the company's pipeline for development.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Oxford Glycosciences
Article Abstract:
Oxford Glycosciences has developed epertise in genetic links to body chemistry and the creation of proteins, and the development of proteins in human cells. The company's database is being used for drugs research with Pfizer, and the LifeExpress database also has an important client, AstraZeneca. The company's drugs pipeline is somewhat weak, and imitators could use its database idea. Oxford has renegotiated an agreement with Searle for OGT, a treatment for Gucher's disease, which would reduce royalties that would have to be paid to Searle.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1999
User Contributions:
Comment about this article or add new information about this topic: